CarnoSyn Brands to Present TriBsyn at the 46th ESPEN Congress on Clinical Nutrition and Metabolism

CARLSBAD, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) — Natural Alternatives International, Inc. (NAI) and CarnoSyn Brands will be exhibiting at the 46^and ESPEN Congress on Clinical Nutrition and Metabolism in Milan, Italy, from 7 to 10 September 2024. ESPEN 2024 offers companies a unique platform to present and educate about innovative science in the field of clinical nutrition and metabolism. The congress encourages collaboration with physicians, dietitians, pharmacists, nutritionists, scientists and nurses.

The NAI and CarnoSyn Brands team will be at booth #16 to discuss the latest clinical evidence of TriBsyn, a patent-pending formulation that utilizes proprietary technology to increase the bioavailability and absorption of beta-alanine while effectively eliminating the common paresthesia sensation associated with effective doses of beta-alanine. TriBsyn represents a new opportunity to reach untapped consumers, from seniors to vegans and anyone focused on wellness. Conference attendees are invited to visit the booth to learn more about this new product innovation.